Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05553652 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of ASTARTE™ on Recurrent Urinary Tract Infection

Study acronym: rUTI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 23, 2022 (before its estimated August 1, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Investigate the effect of dietary supplements/probiotic ASTARTE™ ( L. crispatus, L. rhamnosus, L. jensenii, L. gasseri) on the microbiome composition in the intestine and vagina and thereby a reduction of risk factors for the development of rUTI during 6 months of intervention in women aged 18-40 years. This is measured by the incidence of symptomatic UTI.
Trial Details
NCT Number NCT05553652
Lead Sponsor Hvidovre University Hospital
Conditions
(from sponsor)		 Recurrent Urinary Tract Infection
Related terms Urinary Tract Infections
Enrollment 720 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov